Strides Shasun (SS) is a R&D; focussed, vertically integrated pharmaceutical company with an experienced management team and presence across multiple speciality therapeutic segments. Q2FY19 revenue grew by 10% QoQ due to higher sales growth in the US(~27%) and good performance from Africa (49%QoQ). Australian and Regulated markets witnessed healthy growth of 12%&52% (YoY) led by steady margins and better pricings. Change in partnership model in the US (generic) will further improve...